Cargando…
Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
Hypoxia-inducible factors (HIFs), central regulators for cells to adapt to low cellular oxygen levels, are often overexpressed and activated in breast cancer. HIFs modulate the primary transcriptional response of downstream pathways and target genes in response to hypoxia, including glycolysis, angi...
Autores principales: | Luo, Shuang, Jiang, Yu, Anfu Zheng, Zhao, Yueshui, Wu, Xu, Li, Mingxing, Du, Fukuan, Chen, Yu, Deng, Shuai, Chen, Meijuan, Li, Wanping, Li, Xiaobing, Gu, Li, Sun, Yuhong, Xiao, Zhangang, Shen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751339/ https://www.ncbi.nlm.nih.gov/pubmed/36532768 http://dx.doi.org/10.3389/fphar.2022.1064661 |
Ejemplares similares
-
Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma
por: Chen, Yao, et al.
Publicado: (2022) -
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022) -
Circular RNAs in the Regulation of Oxidative Stress
por: Zhang, Yao, et al.
Publicado: (2021) -
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022) -
Therapeutic prospects of ceRNAs in COVID-19
por: Liu, Lin, et al.
Publicado: (2022)